Published in Hepatitis Weekly, December 19th, 2005
"An estimated 170 million individuals worldwide are infected with HCV, a serious cause of chronic liver disease. Current interferon-based therapy for treating HCV infection has an unsatisfactory cure rate, and the development of more efficient drugs is needed," wrote H. Sakamoto and colleagues, Chugai Pharmaceutical Co. Ltd.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.